<DOC>
	<DOCNO>NCT00292552</DOCNO>
	<brief_summary>This 3 year longitudinal study identify novel endpoint compare standard measure force expiratory volume 1 second ( FEV1 ) ability measure predict COPD ( Chronic Obstructive Pulmonary Disease ) severity progression time . Control subject ( smoker never smoker ) recruit comparators COPD subject .</brief_summary>
	<brief_title>Evaluation COPD ( Chronic Obstructive Pulmonary Disease ) Longitudinally Identify Predictive Surrogate Endpoints</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Inclusion criterion : COPD Subjects A COPD subject eligible inclusion study follow criterion apply : Male female subject , age 4075 year inclusive A baseline ( postbronchodilator ) FEV1 &lt; 80 % predict normal baseline ( postbronchodilator ) FEV1/FVC ratio 70 % Current exsmokers smoke history least 10 packyears ( number pack year = ( number cigarette per day / 20 ) x number year smoke e.g. , 20 cigarette per day 10 year , 10 cigarette per day 20 year ) . A signed date write informed consent obtain prior participation Able comply requirement protocol available study visit 3 year Control Subjects Current/Ex Smokers A control subject eligible inclusion study follow criterion apply : Male female subject , age 4075 year inclusive , free significant disease determine history , physical examination screen investigation Baseline ( postbronchodilator ) FEV1 &gt; 85 % predict normal . FEV1/FVC ratio &gt; 70 % Current exsmokers smoke history least 10 packyears ( number pack year = ( number cigarette per day / 20 ) x number year smoke e.g. , 20 cigarette per day 10 year , 10 cigarette per day 20 year ) . A signed date write informed consent obtain prior participation . Able comply requirement protocol available study visit 3 year Control Subjects Nonsmokers A nonsmoking control subject eligible inclusion study follow criterion apply : Male female subject , age 4075 year inclusive , free significant disease determine history , physical examination screen investigation Baseline ( postbronchodilator ) FEV1 &gt; 85 % predict normal . FEV1/FVC ratio &gt; 70 % Nonsmokers smoke history &lt; 1 packyear ( number pack year = ( number cigarette per day / 20 ) x number year smoke ) . A signed date write informed consent obtain prior participation . Able comply requirement protocol available study visit 3 year COPD Subjects A COPD subject eligible inclusion study follow criterion apply : Known respiratory disorder , disorder identify screening/visit 1 ( include identification first CT scan ) , COPD ( e.g . : lung cancer , sarcoidosis , tuberculosis , lung fibrosis , cystic fibrosis ) Known history significant inflammatory disease , COPD ( e.g . rheumatoid arthritis Lupus ) Known severely alpha1antitrypsin deficient ( PI SZ ZZ ) Having undergone lung surgery ( e.g . lung reduction , lung transplant ) Have cancer cancer 5 year prior study entry Serious , uncontrolled disease ( include serious psychological disorder ) likely interfere study impact subject safety Is enrol long term blind drug study ( subject open label study may consider subject short blind study ( approx less 12 week may consider follow consultation sponsor ) study significant radiation exposure ( e.g . : CT scan ) Have , opinion investigator , evidence alcohol , drug solvent abuse Have receive blood transfusion 4 week prior study start Has experience moderate severe exacerbation ( require oral corticosteroid , antibiotic hospitalisation ) within last 4 week . All course oral corticosteroid antibiotic must complete least 2 week study start Is long term oral corticosteroid ( long term consider use 3 consecutive month ) Unable walk Subject participate investigator , subinvestigator , study coordinator , employee participate investigator , immediate family member aforementioned . Control Subjects A control subject eligible inclusion study follow criterion apply : Known respiratory disorder , disorder identify screening/visit 1 include identification first CT scan ( e.g . : COPD , asthma , lung cancer , sarcoidosis , tuberculosis , lung fibrosis ) Known history significant inflammatory disease ( eg rheumatoid arthritis Lupus ) Known severely alpha1antitrypsin deficient ( PI SZ ZZ ) Having undergone lung surgery ( e.g . lung reduction , lung transplant ) Have cancer cancer 5 year prior study entry Serious , uncontrolled disease ( include serious psychological disorder ) likely interfere study Is enrol long term blind drug study ( subject open label study may consider subject short blind study ( approx less 12 week may consider follow consultation sponsor ) study significant radiation exposure ( e.g . : CT scan ) Have , opinion investigator , evidence alcohol , drug solvent abuse . Have receive blood transfusion 4 week prior study start Is long term oral corticosteroid ( long term consider use 3 consecutive month ) Subject participate investigator , subinvestigator , study coordinator , employee participate investigator , immediate family member aforementioned .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease ( COPD )</keyword>
	<keyword>longitudinal</keyword>
	<keyword>eclipse</keyword>
</DOC>